Clinical Trial Update: Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacoscintigraphic study of NN9924 in healthy male volunteers, sponsored by Novo Nordisk A/S, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NN9924

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED